explore -WSS

explore

author：hotspot 2025-08-12 09:11:40 - browse：8175

A person wears five fitness tracking watches on their wrist — first opinion coverage from STAT — Bebeto Matthews/AP

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

That’s great news for the $45 billion fitness tracking industry, which spends vast sums on advertising designed to convince us that data is the key to better living. The marketing campaigns work: Each January, fitness app downloads spike 36% higher than usual. We’ve also seen the rise of over 400 personalized nutrition companies, while over 12 million people have sequenced their DNA through 23andMe.

Only one problem: The data isn’t working. At least 1.4 million Americans are diagnosed with diabetes each year. Obesity rates soared from 31% to 42% over the past decade. Life expectancy is declining. We were told data would put us in control, but we’re actually less healthy than ever.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Think you might have Covid

Wikipedia

WSS

Maui funeral service workers on devastation of fires: 'I'm in shock'

eGenesis tests gene

Independent physicians launch a new lobbying group

Kim Kardashian sparks debate on benefits of full

Readout Newsletter: Merck, J&J, and long Covid

eGenesis tests gene

knowledge

explore

focus

What does generative AI mean for health care? We asked experts

Eli Lilly, Pfizer, and others want in on the online prescription market

DIEP, the 'gold standard' of breast reconstruction, is under threat

Genentech weighs delaying cancer therapy after drug pricing law

Hepatitis C has a cure — but many Americans still lack access to it

Genentech weighs delaying cancer therapy after drug pricing law

Virginia high school admissions case could be legal follow

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Wildfire smoke exposes gaps in outdoor worker protections

Biotech venture capitalists face new demands from investors

leisure time

Some of the ways extreme heat will change life as we know it

Timeline: Special counsel's investigation into Trump's handling of classified documents

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

TB outbreak tied to bone grafts underscores testing shortcomings

Novo acquires Inversago for up to $1 billion

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Wikipedia

entertainment

hotspot

entertainment